{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:41:56Z","timestamp":1784950916111,"version":"3.55.0"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bcp.2025.117531","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:41:02Z","timestamp":1762645262000},"page":"117531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P2","title":["GPR39 and GPR40 in epilepsy: a potential therapeutic target for rational drug design, pathophysiology, current understanding and challenges"],"prefix":"10.1016","volume":"243","author":[{"given":"Emmanuel Oshiogwe","family":"Okwuofu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaila Musa","family":"Chiroma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreenivasulu","family":"Sura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey Yong","family":"Chee Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asani","family":"Ajogun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117531_b0005","doi-asserted-by":"crossref","unstructured":"J. Xue, X. Li, Y. Zhao, W. Jia, X. Wu, S. Jiang et al., Global, regional, and national burden of idiopathic epilepsy in older adults 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. BMC Med. 23(1). 443. 2025, doi: 10.1186\/s12916-025-04268-8.","DOI":"10.1186\/s12916-025-04268-8"},{"issue":"4","key":"10.1016\/j.bcp.2025.117531_b0010","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","article-title":"Lee et al., Epileptic seizures and epilepsy: definitions proposed by the International League against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2025.117531_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2019.106192","article-title":"Epilepsy-related and other causes of mortality in people with epilepsy: a systematic review of systematic reviews","volume":"157","author":"Mbizvo","year":"2019","journal-title":"Epilepsy Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117531_b0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12955-022-02086-7","article-title":"Co-morbid mental health conditions in people with epilepsy and association with quality of life in low- and middle-income countries: a systematic review and meta-analysis","volume":"21","author":"Tsigebrhan","year":"2023","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.bcp.2025.117531_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1269241","article-title":"Neuroinflammation in epileptogenesis: from pathophysiology to therapeutic strategies","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117531_b0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.seizure.2020.09.015","article-title":"Inflammatory and immune mechanisms underlying epileptogenesis and epilepsy: from pathogenesis to treatment target","volume":"82","author":"Mukhtar","year":"2020","journal-title":"Seizure"},{"issue":"4","key":"10.1016\/j.bcp.2025.117531_b0035","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11011-021-00684-w","article-title":"Creatine attenuates seizure severity, anxiety and depressive-like behaviors in pentylenetetrazole kindled mice","volume":"36","author":"Okwuofu","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bcp.2025.117531_b0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.eplepsyres.2015.08.010","article-title":"Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors","volume":"117","author":"Aghaei","year":"2015","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.bcp.2025.117531_b0045","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3389\/fphar.2018.00451","article-title":"Effects of antiepileptic drugs on spontaneous recurrent seizures in a novel model of extended hippocampal kindling in mice","volume":"9","author":"Song","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117531_b0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00018-023-04766-z","article-title":"TC-G 1008 facilitates epileptogenesis by acting selectively at the GPR39 receptor but non-selectively activates CREB in the hippocampus of pentylenetetrazole-kindled mice","volume":"80","author":"Doboszewska","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2025.117531_b0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.nbd.2017.07.006","article-title":"GPR37L1 modulates seizure susceptibility: evidence from mouse studies and analyses of a human GPR37L1 variant","volume":"106","author":"Giddens","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bcp.2025.117531_b0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.nbd.2014.12.020","article-title":"Homeostatic regulation of KCC2 activity by the zinc receptor mZnR\/GPR39 during seizures","volume":"81","author":"Gilad","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.bcp.2025.117531_b0065","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau2357","article-title":"GPR40 modulates epileptic seizure and NMDA receptor function","volume":"4","author":"Yang","year":"2018","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.bcp.2025.117531_b0070","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/cns.14174","article-title":"Signaling pathway mechanisms of neurological diseases induced by G protein-coupled receptor 39","volume":"29","author":"Cao","year":"2023","journal-title":"CNS Neurosci. Ther."},{"issue":"12","key":"10.1016\/j.bcp.2025.117531_b0075","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.bbadis.2015.09.003","article-title":"The zinc binding receptor GPR39 interacts with 5-HT1A and GalR1 to form dynamic heteroreceptor complexes with signaling diversity","volume":"1852","author":"Tena-Campos","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.bcp.2025.117531_b0080","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/s41594-021-00674-7","article-title":"GPCR activation mechanisms across classes and macro\/microscales","volume":"28","author":"Hauser","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"7945","key":"10.1016\/j.bcp.2025.117531_b0085","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41586-022-05588-y","article-title":"Structure-based design of bitopic ligands for the \u00b5-opioid receptor","volume":"613","author":"Faouzi","year":"2023","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bcp.2025.117531_b0090","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cell.2017.07.009","article-title":"How ligands illuminate GPCR molecular pharmacology","volume":"170","author":"Wacker","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2025.117531_b0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-020-00435-w","article-title":"G protein-coupled receptors: structure- and function-based drug discovery","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2025.117531_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.931573","article-title":"GPCR heteromers: an overview of their classification, function and physiological relevance","volume":"13","author":"Dale","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"6","key":"10.1016\/j.bcp.2025.117531_b0105","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1111\/j.1476-5381.2011.01629.x","article-title":"Lifting the lid on GPCRs: the role of extracellular loops","volume":"165","author":"Wheatley","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117531_b0110","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.tibs.2021.08.006","article-title":"Deconstructing the transmembrane core of class a G protein-coupled receptors","volume":"46","author":"Smith","year":"2021","journal-title":"Trends Biochem. Sci"},{"issue":"1","key":"10.1016\/j.bcp.2025.117531_b0115","doi-asserted-by":"crossref","first-page":"11669","DOI":"10.1038\/s41598-020-68355-x","article-title":"The discovery of a new antibody for BRIL-fused GPCR structure determination","volume":"10","author":"Miyagi","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2025.117531_b0120","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1038\/s41467-020-16975-2","article-title":"Structural mechanism underlying primary and secondary coupling between GPCRs and the Gi\/o family","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117531_b0125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.sbi.2016.11.005","article-title":"Mechanistic insights into GPCR-G protein interactions","volume":"41","author":"Mahoney","year":"2016","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"8","key":"10.1016\/j.bcp.2025.117531_b0130","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/bip.22836","article-title":"Invited review: activation of G proteins by GTP and the mechanism of G\u03b1-catalyzed GTP hydrolysis","volume":"105","author":"Sprang","year":"2016","journal-title":"Biopolymers"},{"issue":"5544","key":"10.1016\/j.bcp.2025.117531_b0135","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.294.5544.1024","article-title":"The neurobiology of slow synaptic transmission","volume":"294","author":"Greengard","year":"2001","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bcp.2025.117531_b0140","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.devcel.2009.09.011","article-title":"Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways","volume":"17","author":"Kovacs","year":"2009","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bcp.2025.117531_b0145","doi-asserted-by":"crossref","unstructured":"G. Chen, R. G. Xie, Y. J. Gao, Z. Z. Xu, L. X. Zhao, S. Bang et al., \u03b2-arrestin-2 regulates NMDA receptor function in spinal lamina II neurons and duration of persistent pain, Nat Commun. 7. 12531. 19 2016, doi: 10.1038\/ncomms12531.","DOI":"10.1038\/ncomms12531"},{"issue":"10","key":"10.1016\/j.bcp.2025.117531_b0150","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1042\/BCJ20253088","article-title":"GPCR signaling via cAMP nanodomains","volume":"482","author":"Yadav","year":"2025","journal-title":"Biochem. J"},{"issue":"5","key":"10.1016\/j.bcp.2025.117531_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108718","article-title":"G\u03b1o is a major determinant of cAMP signaling in the pathophysiology of movement disorders","volume":"34","author":"Muntean","year":"2021","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.bcp.2025.117531_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11092347","article-title":"Intracellular cAMP signaling pathway via G(s) protein-coupled receptor activation in rat primary cultured trigeminal ganglion cells","volume":"11","author":"Kunioku","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.bcp.2025.117531_b0165","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.pharmthera.2004.12.005","article-title":"Sensitization of adenylate cyclase by G\u03b1i\/o-coupled receptors","volume":"106","author":"Watts","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2025.117531_b0170","doi-asserted-by":"crossref","unstructured":"N. Guo, X. Wang, M. Xu, J. Bai, H. Yu, and Z. Le, PI3K\/AKT signaling pathway: Molecular mechanisms and therapeutic potential in depression. Pharmacol Res. 206. 107300. doi: 10.1016\/j.phrs.2024.107300.","DOI":"10.1016\/j.phrs.2024.107300"},{"issue":"1","key":"10.1016\/j.bcp.2025.117531_b0175","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12974-021-02325-6","article-title":"Dysregulated phosphoinositide 3-kinase signaling in microglia: shaping chronic neuroinflammation","volume":"18","author":"Chu","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.bcp.2025.117531_b0180","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bpsgos.2022.03.010","article-title":"Dysfunction of cAMP-protein kinase A-calcium signaling axis in striatal medium spiny neurons: a role in schizophrenia and Huntington's disease neuropathology","volume":"3","author":"Fjodorova","year":"2023","journal-title":"Biol Psychiatry Glob Open Sci."},{"issue":"6","key":"10.1016\/j.bcp.2025.117531_b0185","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/glia.23589","article-title":"G(i\/o) protein-coupled receptors inhibit neurons but activate astrocytes and stimulate gliotransmission","volume":"67","author":"Durkee","year":"2019","journal-title":"Glia"},{"issue":"6","key":"10.1016\/j.bcp.2025.117531_b0190","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.bbamcr.2008.10.005","article-title":"Inositol trisphosphate and calcium signalling mechanisms","volume":"1793","author":"Berridge","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2025.117531_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.615569","article-title":"Role of oxidative stress and Ca(2+) signaling in psychiatric disorders","volume":"9","author":"Nakao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117531_b0200","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0898-6568(03)00132-3","article-title":"Role of Lbc RhoGEF in Galpha12\/13-induced signals to Rho GTPase","volume":"16","author":"Dutt","year":"2004","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bcp.2025.117531_b0205","article-title":"The RHO Family GTPases: Mechanisms of Regulation and Signaling","volume":"10(7). 20","author":"Mosaddeghzadeh","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bcp.2025.117531_b0210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1476-5381.2009.00121.x","article-title":"Regulation of RhoGEF proteins by G12\/13-coupled receptors","volume":"158","author":"Siehler","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117531_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.03.008","article-title":"ROCK inhibition in models of neurodegeneration and its potential for clinical translation","volume":"189","author":"Koch","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.bcp.2025.117531_b0220","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/labinvest.2010.104","article-title":"Role of serum response factor in the pathogenesis of disease","volume":"90","author":"Miano","year":"2010","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bcp.2025.117531_b0225","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.conb.2020.03.010","article-title":"Breaking symmetry - cell polarity signaling pathways in growth cone guidance and synapse formation","volume":"63","author":"Zou","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.bcp.2025.117531_b0230","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fncel.2014.00314","article-title":"Rho family GTPases: key players in neuronal development, neuronal survival, and neurodegeneration","volume":"8","author":"Stankiewicz","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.bcp.2025.117531_b0235","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/cells9020506","article-title":"G-Protein-coupled receptors in CNS: a potential therapeutic target for intervention in neurodegenerative disorders and associated cognitive deficits","volume":"9","author":"Azam","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bcp.2025.117531_b0240","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41392-024-01803-6","article-title":"G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2025.117531_b0245","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8425640","article-title":"Insights into the promising prospect of G protein and GPCR-mediated signaling in neuropathophysiology and its therapeutic regulation","author":"Rahman","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"5","key":"10.1016\/j.bcp.2025.117531_b0250","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj3808","article-title":"GPR39 regulated spinal glycinergic inhibition and mechanical inflammatory pain","volume":"10","author":"Bai","year":"2024","journal-title":"Sci. Adv."},{"issue":"11","key":"10.1016\/j.bcp.2025.117531_b0255","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2174\/1570159X19666210225153404","article-title":"Interaction between Zinc, GPR39, BDNF and neuropeptides in depression","volume":"19","author":"Mlyniec","year":"2021","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117531_b0260","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41392-023-01427-2","article-title":"G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders","volume":"8","author":"Wong","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.bcp.2025.117531_b0265","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.tins.2024.05.008","article-title":"Emerging modes of regulation of neuromodulatory G protein-coupled receptors","volume":"47","author":"Gonzalez-Hernandez","year":"2024","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bcp.2025.117531_b0270","doi-asserted-by":"crossref","unstructured":"U. Doboszewska, K. Soca\u0142a, M. Pier\u00f3g, D. Nieoczym, J. Sawicki, A. Sajn\u00f3g et al., Dietary Zinc Differentially Regulates the Effects of the GPR39 Receptor Agonist, TC-G 1008, in the Maximal Electroshock Seizure Test and Pentylenetetrazole-Kindling Model of Epilepsy, Cells. 12(2) 2023, doi: 10.3390\/cells12020264.","DOI":"10.3390\/cells12020264"},{"key":"10.1016\/j.bcp.2025.117531_b0275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.seizure.2021.04.008","article-title":"Cannabidiol modifies the seizure expression and effects of antiseizure drugs in a rat model of recurrent severe seizures","volume":"90","author":"Fr\u00edas-Soria","year":"2021","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.bcp.2025.117531_b0280","doi-asserted-by":"crossref","first-page":"14945","DOI":"10.1038\/s41598-017-15015-2","article-title":"In vivo monitoring for regional changes of metabotropic glutamate receptor subtype 1 (mGluR1) in pilocarpine-induced epileptic rat brain by small-animal PET","volume":"7","author":"Yamasaki","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117531_b0285","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1282494","article-title":"Involvement of orexin type-2 receptors in genetic absence epilepsy rats","volume":"14","author":"Toplu","year":"2023","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117531_b0290","doi-asserted-by":"crossref","first-page":"C439","DOI":"10.1152\/ajpcell.00102.2022","article-title":"Neuronal G protein-gated K(+) channels","volume":"323","author":"Luo","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bcp.2025.117531_b0295","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.851394","article-title":"The Function of NF-Kappa B during epilepsy, a potential therapeutic target","volume":"16","author":"Cai","year":"2022","journal-title":"Front. Neurosci."},{"issue":"7","key":"10.1016\/j.bcp.2025.117531_b0300","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/hipo.22263","article-title":"GPR40 activation leads to CREB and ERK phosphorylation in primary cultures of neurons from the mouse CNS and in human neuroblastoma cells","volume":"24","author":"Zamarbide","year":"2014","journal-title":"Hippocampus"},{"issue":"6","key":"10.1016\/j.bcp.2025.117531_b0305","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.3892\/mmr.2020.11614","article-title":"Inhibition of p38 MAPK regulates epileptic severity by decreasing expression levels of A1R and ENT1","volume":"22","author":"Zhou","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2025.117531_b0310","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1186\/s12887-024-04968-9","article-title":"Evaluating the serum levels of zinc, copper, magnesium, and 25-hydroxy vitamin D in children with idiopathic drug-resistant epilepsy; a cross-sectional study","volume":"24","author":"Tavasoli","year":"2024","journal-title":"BMC Pediatr."},{"issue":"1","key":"10.1016\/j.bcp.2025.117531_b0315","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.eplepsyres.2012.09.009","article-title":"The serum zinc, copper, iron, and chromium concentrations in epileptic children","volume":"104","author":"Wojciak","year":"2013","journal-title":"Epilepsy Res."},{"issue":"4","key":"10.1016\/j.bcp.2025.117531_b0320","first-page":"1008","article-title":"Serum zinc level in children presenting with febrile seizures","volume":"29","author":"Waqar Rabbani","year":"2013","journal-title":"Pak J. Med. Sci."},{"key":"10.1016\/j.bcp.2025.117531_b0325","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fncel.2012.00005","article-title":"Role of the neuronal K-Cl co-transporter KCC2 in inhibitory and excitatory neurotransmission","volume":"6","author":"Chamma","year":"2012","journal-title":"Front. Cell. Neurosci."},{"issue":"31","key":"10.1016\/j.bcp.2025.117531_b0330","doi-asserted-by":"crossref","first-page":"29031","DOI":"10.1074\/jbc.M302751200","article-title":"Regulation of canonical transient receptor potential (TRPC) channel function by diacylglycerol and protein kinase C","volume":"278","author":"Venkatachalam","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2025.117531_b0335","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1248\/bpb.28.1342","article-title":"Neuronal Ca2+\/calmodulin-dependent protein kinase II\u2013discovery, progress in a quarter of a century, and perspective: implication for learning and memory","volume":"28","author":"Yamauchi","year":"2005","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.bcp.2025.117531_b0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-008-8051-0","article-title":"Human BDNF isoforms are differentially expressed in cocaine addicts and are sorted to the regulated secretory pathway independent of the Met66 substitution","volume":"11","author":"Jiang","year":"2009","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.bcp.2025.117531_b0345","article-title":"The role of brain-derived neurotrophic factor in epileptogenesis: an update","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117531_b0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000573","article-title":"Corticolimbic expression of TRPC4 and TRPC5 channels in the rodent brain","volume":"2","author":"Fowler","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117531_b0355","doi-asserted-by":"crossref","unstructured":"F. Zheng, Canonical Transient Receptor Potential Channels as Novel Targets for Antiepileptic Drugs, in Epilepsy, S. J. Czuczwar Ed. Brisbane (AU): Exon Publications Copyright: The Authors.; The authors confirm that the materials included in this chapter do not violate copyright laws. Where relevant, appropriate permissions have been obtained from the original copyright holder(s), and all original sources have been appropriately acknowledged or referenced., 2022.","DOI":"10.36255\/exon-publications-epilepsy-trpc"},{"issue":"2","key":"10.1016\/j.bcp.2025.117531_b0360","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4196\/kjpp.2023.27.2.187","article-title":"Negative self-regulation of transient receptor potential canonical 4 by the specific interaction with phospholipase C-\u03b41","volume":"27","author":"Ko","year":"2023","journal-title":"Korean J. Physiol. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117531_b0365","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cellsig.2004.09.005","article-title":"The overexpression of presenilin2 and Alzheimer's-disease-linked presenilin2 variants influences TRPC6-enhanced Ca2+ entry into HEK293 cells","volume":"17","author":"Lessard","year":"2005","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.bcp.2025.117531_b0370","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.cell.2009.03.039","article-title":"Essential role for TRPC5 in amygdala function and fear-related behavior","volume":"137","author":"Riccio","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2025.117531_b0375","doi-asserted-by":"crossref","unstructured":"K. Rasmus, J.-G. Wang, A. Varnell, E. Ostertag, and D. Cooper, Sociability is decreased following deletion of the trpc4 gene, Nature Precedings, pp. 1-1, 2011.","DOI":"10.1038\/npre.2011.6367.1"},{"key":"10.1016\/j.bcp.2025.117531_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115990","article-title":"Synthetic GPR40\/FFAR1 agonists: an exhaustive survey on the most recent chemical classes and their structure-activity relationships","volume":"264","author":"Paul","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"13","key":"10.1016\/j.bcp.2025.117531_b0385","doi-asserted-by":"crossref","first-page":"11303","DOI":"10.1074\/jbc.M211495200","article-title":"The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids*","volume":"278","author":"Briscoe","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"6928","key":"10.1016\/j.bcp.2025.117531_b0390","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature01478","article-title":"Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40","volume":"422","author":"Itoh","year":"2003","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2025.117531_b0395","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0006-291X(02)03064-4","article-title":"A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs","volume":"301","author":"Kotarsky","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.bcp.2025.117531_b0400","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/hipo.20682","article-title":"Cellular localization of epidermal-type and brain-type fatty acid-binding proteins in adult hippocampus and their response to cerebral ischemia","volume":"20","author":"Ma","year":"2010","journal-title":"Hippocampus"},{"issue":"8","key":"10.1016\/j.bcp.2025.117531_b0405","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s00213-021-05837-4","article-title":"GPR40 receptor agonist TAK-875 improves cognitive deficits and reduces \u03b2-amyloid production in APPswe\/PS1dE9 mice","volume":"238","author":"Liu","year":"2021","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1016\/j.bcp.2025.117531_b0410","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrn3820","article-title":"Polyunsaturated fatty acids and their metabolites in brain function and disease","volume":"15","author":"Bazinet","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"issue":"Pt B","key":"10.1016\/j.bcp.2025.117531_b0415","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuropharm.2015.05.013","article-title":"The role of polyunsaturated fatty acids and GPR40 receptor in brain","volume":"113","author":"Khan","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2025.117531_b0420","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/jnnp-2014-307749","article-title":"Fish oil (n-3 fatty acids) in drug resistant epilepsy: a randomised placebo-controlled crossover study","volume":"86","author":"DeGiorgio","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bcp.2025.117531_b0425","doi-asserted-by":"crossref","unstructured":"M. L\u00e9vesque and M. Avoli, The kainic acid model of temporal lobe epilepsy, Neurosci Biobehav Rev. 37(10) Pt 2, pp. 2887-99. 2013, doi: 10.1016\/j.neubiorev.2013.10.011.","DOI":"10.1016\/j.neubiorev.2013.10.011"},{"key":"10.1016\/j.bcp.2025.117531_b0430","doi-asserted-by":"crossref","unstructured":"B. Monteiro \u00c1, A. F. Alves, A. C. Ribeiro Portela, H. F. Oliveira Pires, M. Pessoa de Melo, N. M. Medeiros Vilar Barbosa et al., Pentylenetetrazole: A review, Neurochem Int. 180. 105841. 2024, doi: 10.1016\/j.neuint.2024.105841.","DOI":"10.1016\/j.neuint.2024.105841"},{"key":"10.1016\/j.bcp.2025.117531_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107432","article-title":"GPR40 agonist ameliorates neurodegeneration and motor impairment by regulating NLRP3 inflammasome in Parkinson\u2019s disease animal models","volume":"209","author":"Ha","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2025.117531_b0440","article-title":"Roles of N-Methyl-D-Aspartate Receptors (NMDARs) in Epilepsy","volume":"14","author":"Chen","year":"2021","journal-title":"Front. Mol. Neurosci."},{"issue":"Suppl 6","key":"10.1016\/j.bcp.2025.117531_b0445","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/epi.12285","article-title":"Trafficking of NMDA receptors during status epilepticus: therapeutic implications","volume":"54","author":"Wasterlain","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2025.117531_b0450","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fncel.2019.00077","article-title":"Alterations in GABAA-receptor trafficking and synaptic dysfunction in brain disorders","volume":"13","author":"Mele","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.bcp.2025.117531_b0455","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1523\/JNEUROSCI.3607-06.2007","article-title":"Differential roles of NR2A- and NR2B-containing NMDA receptors in activity-dependent brain-derived neurotrophic factor gene regulation and limbic epileptogenesis","volume":"27","author":"Chen","year":"2007","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117531_b0460","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12974-021-02209-9","article-title":"Activation of GPR40 attenuates neuroinflammation and improves neurological function via PAK4\/CREB\/KDM6B pathway in an experimental GMH rat model","volume":"18","author":"Xiao","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bcp.2025.117531_b0465","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12990-015-0003-8","article-title":"Oyoshi et al., Attenuation of inflammatory and neuropathic pain behaviors in mice through activation of free fatty acid receptor GPR40","volume":"11","author":"Karki","year":"2015","journal-title":"Mol. Pain"},{"issue":"1","key":"10.1016\/j.bcp.2025.117531_b0470","doi-asserted-by":"crossref","first-page":"11047","DOI":"10.1038\/s41598-020-68110-2","article-title":"Activation of GPR40 induces hypothalamic neurogenesis through p38- and BDNF-dependent mechanisms","volume":"10","author":"Engel","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117531_b0475","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.nbd.2018.07.002","article-title":"Docosahexaenoic acid modulates brain-derived neurotrophic factor via GPR40 in the brain and alleviates diabesity-associated learning and memory deficits in mice","volume":"118","author":"Sona","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bcp.2025.117531_b0480","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuroscience.2012.03.001","article-title":"SNARE-dependent upregulation of potassium chloride co-transporter 2 activity after metabotropic zinc receptor activation in rat cortical neurons in vitro","volume":"210","author":"Saadi","year":"2012","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.bcp.2025.117531_b0485","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1523\/JNEUROSCI.5093-08.2009","article-title":"Synaptically released zinc triggers metabotropic signaling via a zinc-sensing receptor in the hippocampus","volume":"29","author":"Besser","year":"2009","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.bcp.2025.117531_b0490","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/00207454.2013.831851","article-title":"Trace element, oxidant, and antioxidant enzyme values in blood of children with refractory epilepsy","volume":"124","author":"Saad","year":"2014","journal-title":"Int. J. Neurosci."},{"issue":"Pt 9","key":"10.1016\/j.bcp.2025.117531_b0495","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1113\/jphysiol.2009.181826","article-title":"The K+-Cl cotransporter KCC2 promotes GABAergic excitation in the mature rat hippocampus","volume":"588","author":"Viitanen","year":"2010","journal-title":"J. Physiol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117531_b0500","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.tins.2013.08.006","article-title":"Modulation of neuronal activity by phosphorylation of the K-Cl cotransporter KCC2","volume":"36","author":"Kahle","year":"2013","journal-title":"Trends Neurosci."},{"issue":"4","key":"10.1016\/j.bcp.2025.117531_b0505","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1179\/1476830513Y.0000000105","article-title":"Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: a double-blind, randomized, placebo-controlled trial","volume":"18","author":"Solati","year":"2015","journal-title":"Nutr. Neurosci."},{"issue":"5","key":"10.1016\/j.bcp.2025.117531_b0510","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.tins.2021.01.004","article-title":"The Multifaceted Roles of KCC2 in Cortical Development","volume":"44","author":"Virtanen","year":"2021","journal-title":"Trends Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.bcp.2025.117531_b0515","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.eplepsyres.2008.02.005","article-title":"NKCC1 and KCC2 prevent hyperexcitability in the mouse hippocampus","volume":"79","author":"Zhu","year":"2008","journal-title":"Epilepsy Res."},{"issue":"36","key":"10.1016\/j.bcp.2025.117531_b0520","doi-asserted-by":"crossref","first-page":"12916","DOI":"10.1523\/JNEUROSCI.2205-11.2011","article-title":"Upregulation of KCC2 activity by zinc-mediated neurotransmission via the mZnR\/GPR39 receptor","volume":"31","author":"Chorin","year":"2011","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.bcp.2025.117531_b0525","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/embr.201438749","article-title":"A variant of KCC2 from patients with febrile seizures impairs neuronal Cl- extrusion and dendritic spine formation","volume":"15","author":"Puskarjov","year":"2014","journal-title":"EMBO Rep."},{"issue":"36","key":"10.1016\/j.bcp.2025.117531_b0530","doi-asserted-by":"crossref","first-page":"12028","DOI":"10.1523\/JNEUROSCI.3154-10.2010","article-title":"A single seizure episode leads to rapid functional activation of KCC2 in the neonatal rat hippocampus","volume":"30","author":"Khirug","year":"2010","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.bcp.2025.117531_b0535","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/jnc.13367","article-title":"Regulation of neuronal pH by the metabotropic Zn(2+)-sensing Gq-coupled receptor, mZnR\/GPR39","volume":"135","author":"Ganay","year":"2015","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.bcp.2025.117531_b0540","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.bbrc.2010.02.078","article-title":"Galanin receptor-1 modulates 5-hydroxtryptamine-1A signaling via heterodimerization","volume":"393","author":"Borroto-Escuela","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.bcp.2025.117531_b0545","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/01.wnr.0000215779.76602.93","article-title":"GPR39 receptor expression in the mouse brain","volume":"17","author":"Jackson","year":"2006","journal-title":"Neuroreport"},{"issue":"4","key":"10.1016\/j.bcp.2025.117531_b0550","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1007\/s12035-017-0536-0","article-title":"Allosteric Inhibition of Serotonin 5-HT(7) Receptors by Zinc Ions","volume":"55","author":"Sata\u0142a","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117531_b0555","doi-asserted-by":"crossref","first-page":"C1011","DOI":"10.1152\/ajpcell.00454.2021","article-title":"Control of coronary vascular resistance by eicosanoids via a novel GPCR","volume":"322","author":"Alkayed","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"28","key":"10.1016\/j.bcp.2025.117531_b0560","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2308227120","article-title":"GPR39 deorphanization: the long and winding road to eicosanoids and a crosstalk between GPR39 and hedgehog signaling in angiogenesis","volume":"120","author":"Doboszewska","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bcp.2025.117531_b0565","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1152\/jn.00285.2024","article-title":"On the genesis and unique functions of zinc neuromodulation","volume":"132","author":"Bizup","year":"2024","journal-title":"J. Neurophysiol."},{"issue":"51","key":"10.1016\/j.bcp.2025.117531_b0570","doi-asserted-by":"crossref","first-page":"53806","DOI":"10.1074\/jbc.M407676200","article-title":"Common structural basis for constitutive activity of the ghrelin receptor family","volume":"279","author":"Holst","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117531_b0575","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1210\/en.2006-0933","article-title":"GPR39 signaling is stimulated by zinc ions but not by obestatin","volume":"148","author":"Holst","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2025.117531_b0580","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pharmthera.2019.05.006","article-title":"Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR\/transducer selectivity and therapeutic potential","volume":"200","author":"Seyedabadi","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2025.117531_b0585","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s43440-023-00478-0","article-title":"The role of GPR39 zinc receptor in the modulation of glutamatergic and GABAergic transmission","volume":"75","author":"Starowicz","year":"2023","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bcp.2025.117531_b0590","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pharmthera.2018.08.013","article-title":"Zinc signaling and epilepsy","volume":"193","author":"Doboszewska","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2025.117531_b0595","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3389\/fnins.2019.00920","article-title":"Long-Term Effects of Zinc Deficiency and Zinc Supplementation on Developmental Seizure-Induced Brain damage and the underlying GPR39\/ZnT-3 and MBP Expression in the Hippocampus","volume":"13","author":"Chen","year":"2019","journal-title":"Front. Neurosci."},{"issue":"10","key":"10.1016\/j.bcp.2025.117531_b0600","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1021\/ml500240d","article-title":"Discovery of 2-Pyridylpyrimidines as the first Orally Bioavailable GPR39 Agonists","volume":"5","author":"Peukert","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2025.117531_b0605","doi-asserted-by":"crossref","unstructured":"S. Xie, X. Jiang, D. M. Doycheva, H. Shi, P. Jin, L. Gao et al., Activation of GPR39 with TC-G 1008attenuates neuroinflammation via SIRT1\/PGC-1\u03b1\/Nrf2 pathway post-neonatal hypoxic-ischemic injury in rats, J Neuroinflammation. 18(1). 226. 2021, doi: 10.1186\/s12974-021-02289-7.","DOI":"10.1186\/s12974-021-02289-7"},{"key":"10.1016\/j.bcp.2025.117531_b0610","doi-asserted-by":"crossref","unstructured":"S. Choi, D. K. Hong, B. Y. Choi, and S. W. Suh, Zinc in the Brain: Friend or Foe?, Int J Mol Sci. 21(23) . 2020, doi: 10.3390\/ijms21238941.","DOI":"10.3390\/ijms21238941"},{"key":"10.1016\/j.bcp.2025.117531_b0615","doi-asserted-by":"crossref","unstructured":"U. Doboszewska, J. Sawicki, A. Sajn\u00f3g, A. Szopa, A. Serefko, K. Soca\u0142a et al., Alterations of Serum Magnesium Concentration in Animal Models of Seizures and Epilepsy-The Effects of Treatment with a GPR39 Agonist and Knockout of the Gpr39 Gene, Cells. 11(13) . 2022, doi: 10.3390\/cells11131987.","DOI":"10.3390\/cells11131987"},{"key":"10.1016\/j.bcp.2025.117531_b0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101682","article-title":"G protein-coupled receptors in acquired epilepsy: Druggability and translatability","volume":"183","author":"Yu","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bcp.2025.117531_b0625","doi-asserted-by":"crossref","unstructured":"F. Cheng, F. Yan, A. Yang, J. Liu, and J. Ma, Activation of G protein-coupled receptor 39 alleviates neuropathic pain and chronic inflammation, J Biochem Mol Toxicol. 38(1). e23545. 2024, doi: 10.1002\/jbt.23545.","DOI":"10.1002\/jbt.23545"},{"key":"10.1016\/j.bcp.2025.117531_b0630","doi-asserted-by":"crossref","unstructured":"M. S. Pohlentz, P. M\u00fcller, S. Cases-Cunillera, T. Opitz, R. Surges, M. Hamed et al., Characterisation of NLRP3 pathway-related neuroinflammation in temporal lobe epilepsy, PLoS One. 17(8). e0271995, 2022, doi: 10.1371\/journal.pone.0271995.","DOI":"10.1371\/journal.pone.0271995"},{"key":"10.1016\/j.bcp.2025.117531_b0635","doi-asserted-by":"crossref","unstructured":"W. A. Osmani, A. Gallo, M. Tabor, M. Eilbes, D. R. Cook-Snyder, and M. R. Hodges, Repeated seizure-induced brainstem neuroinflammation contributes to post-ictal ventilatory control dysfunction, Front Physiol. 15. 1413479, 2024, doi: 10.3389\/fphys.2024.1413479.","DOI":"10.3389\/fphys.2024.1413479"},{"issue":"1","key":"10.1016\/j.bcp.2025.117531_b0640","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00204-023-03628-8","article-title":"Inflammation as common link to progressive neurological diseases","volume":"98","author":"Dias-Carvalho","year":"2024","journal-title":"Arch. Toxicol."},{"issue":"10","key":"10.1016\/j.bcp.2025.117531_b0645","doi-asserted-by":"crossref","first-page":"6869","DOI":"10.1007\/s12035-015-9586-3","article-title":"Concentration-dependent dual mode of Zn action at serotonin 5-HT1A receptors in vitro and in vivo studies","volume":"53","author":"Sata\u0142a","year":"2016","journal-title":"Mol Neurobiol."},{"key":"10.1016\/j.bcp.2025.117531_b0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108574","article-title":"Decreased hippocampal serotonin 5HT(1A) expression in mesial temporal lobe of epilepsy patients","volume":"129","author":"Marinho","year":"2022","journal-title":"Epilepsy Behav."},{"issue":"3","key":"10.1016\/j.bcp.2025.117531_b0655","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuropharm.2005.03.020","article-title":"5-HT1A receptor agonists modify epileptic seizures in three experimental models in rats","volume":"49","author":"L\u00f3pez-Meraz","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2025.117531_b0660","doi-asserted-by":"crossref","unstructured":"U. Doboszewska, K. Socala, M. Pier\u00f3g, D. Nieoczym, J. Sawicki, M. Szafarz et al., The effects and mechanisms of action of TC-G 1008, GPR39 agonist, in animal models of seizures and epilepsy, 2022.","DOI":"10.21203\/rs.3.rs-1182423\/v1"},{"issue":"6","key":"10.1016\/j.bcp.2025.117531_b0665","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1002\/med.22048","article-title":"Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel","volume":"44","author":"Boda","year":"2024","journal-title":"Med. Res. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2025.117531_b0670","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032026","article-title":"Artificial intelligence and machine learning technology driven modern drug discovery and development","volume":"24","author":"Sarkar","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117531_b0675","article-title":"Applying machine learning techniques to predict drug-related side effect: a policy brief","volume":"62","author":"Toni","year":"2025","journal-title":"Inquiry"},{"issue":"12","key":"10.1016\/j.bcp.2025.117531_b0680","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.tips.2017.09.004","article-title":"Temporal bias: time-encoded dynamic GPCR signaling","volume":"38","author":"Grundmann","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117531_b0685","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s43556-023-00156-w","article-title":"Structure, function and drug discovery of GPCR signaling","volume":"4","author":"Cheng","year":"2023","journal-title":"Mol Biomed."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225007968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225007968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:26:15Z","timestamp":1781065575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225007968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":137,"alternative-id":["S0006295225007968"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117531","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GPR39 and GPR40 in epilepsy: a potential therapeutic target for rational drug design, pathophysiology, current understanding and challenges","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117531"}}